A Study of Intraperitoneally Administered AVB-001 in Patients With Serous Adenocarcinoma of the Ovary
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05538624 |
|
Recruitment Status :
Terminated
(Sponsor Decision to close study)
First Posted : September 14, 2022
Last Update Posted : April 24, 2024
|
Sponsor:
Avenge Bio, Inc
Information provided by (Responsible Party):
Avenge Bio, Inc
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | April 1, 2024 |
| Actual Study Completion Date : | April 10, 2024 |